InsiderTradr

Fisher & Paykel Healthcare Corporation Limited (FPH.NZ)

NZSE · NZD · Healthcare · Medical Instruments & Supplies

NZ$48.13 (-1.51%) as of

Key statistics

Market cap
28.31B
P/E (TTM)
61.71
Forward P/E
44.03
EPS (TTM)
0.78
Dividend yield
1.06%
52-week range
32.16 – 49.63
Beta
0.88
Revenue (TTM)
2.31B
Profit margin
20.30%
Analyst target
NZ$45.19
Volume
783.03k

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Headquarters
Auckland, New Zealand
Employees
7,357

fphcare.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks